Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9609 posts found.

screen_shot_2012-09-10_at_10

Ex-Pfizer head joins Red Door as International director

September 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Thomas, Pfizer, Red Door

Andrew Thomas the strategic communications lead for Pfizer’s primary care medicines across Europe and Canada joins Red Door Communications in …
Appointment
lilly corporate hq image

Lilly suffers late-stage cancer blow

September 10, 2012 Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology

Eli Lilly suffered a blow to its oncology programme when a new combination treatment failed to improve overall survival in …
News
merck kgaa image

Merck KGaA licences new cancer candidate

September 10, 2012 Research and Development, Sales and Marketing Cancer, EGFR, Merck KGaA, oncology

Merck KGaA has signed a worldwide licence agreement with Danish company Symphogen which could expand its portfolio of drugs targeting …
News

New product launches – maximise your chance of success

September 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Paul Stuart Kregor, Paul Stuart-Kregor, marketing, product launch

You don’t have to look very far to see that the pharma industry business model is under increased pressure, and …
Feature

Merck KGaA cuts over 10% of German workforce

September 5, 2012 Research and Development

Merck KGaA is to get rid of more than 10% of its workforce in Germany over the next three years …
News

Pharma welcomes Hunt to top health job

September 5, 2012 Research and Development, Sales and Marketing Andrew Lansley, NHS, NHS reform

The ABPI has used health secretary Andrew Lansley’s demotion at prime minister David Cameron’s first major cabinet reshuffle to restate …
News

Pfizer to develop phase II cancer vaccine

September 4, 2012 Research and Development, Sales and Marketing Cancer, Pfizer, VLST, cancer vaccine

Pfizer has licensed a cancer compound which is ready for phase II study from a US firm specialising in cancer …
News

Contract research news in brief

September 4, 2012 Research and Development CRO, Charles River, WuXi

 Charles River Laboratories (CRL) has paid $17 million for Accugenix, a company which provides endotoxin detection and microbial identity testing …
News
Novartis

Novartis cheered by COPD trial results

September 3, 2012 Research and Development COPD, ERS, Novartis

One of Novartis’ experimental respiratory drugs has proved superior in a late-stage trial to Boehringer Ingelheim and Pfizer’s existing brand …
News

Allergan signs $1.5 billion deal with Molecular Partners

August 22, 2012 Research and Development, Sales and Marketing Allergan, Molecular Partners, eye diseases

Allergan has signed a deal potentially worth $1.5 billion with Molecular Partners to develop new drugs for certain eye diseases. …
News
screen_shot_2012-08-22_at_09

Lundbeck makes two senior appointments

August 22, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andreas Eggert, Klaus Abel, Lundbeck

Lundbeck has appointed Andreas Eggert (pictured) as senior vice president for global product strategy, and Klaus Abel as vice president …
Appointment

Pfizer’s arthritis drug delayed by FDA

August 21, 2012 Research and Development, Sales and Marketing FDA, Pfizer, tofacitinib

Pfizer says its new rheumatoid arthritis drug tofacitinib has been delayed by the FDA. Tofacitinib, an oral Janus kinase (JAK) …
News
screen_shot_2012-08-21_at_09

INC Research promotes Jamie Macdonald to chief executive

August 21, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing INC Research, Jamie Macdonald

Clinical research organisation INC Research has announced chief operating officer Jamie Macdonald will become the firm’s next president and chief …
Appointment

GSK severe asthma drug progresses to Phase III

August 20, 2012 Research and Development, Sales and Marketing Advair, GSK, Phase II, asthma, phase III

GlaxoSmithKline’s severe asthma drug mepolizumab has impressed in a mid-stage study, meaning it can now progress into Phase III testing. …
News

Zaicom MMC appoints new medical writer

August 17, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Katharine Peregrín, Zaicom MMC

Comms agency Zaicom MMC, part of the Zaicom International group of companies, has appointed Katharine Peregrín as a medical writer.  …
Appointment
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026